Related Experiment Video
Updated: Jan 31, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression
Jinfang Zhang1, Ming Chen2, Yasheng Zhu3
1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Abstract:
Frequent SPOP mutation defines the molecular feature underlying one of seven sub-types of human prostate cancer (PrCa). However, it remains largely elusive how SPOP functions as a tumor suppressor in PrCa. Here, we report that SPOP suppresses stem cell traits of both embryonic stem cells and PrCa cells through promoting Nanog poly-ubiquitination and subsequent degradation. Mechanistically, Nanog, but not other pluripotency-determining factors including Oct4, Sox2, and Klf4, specifically interacts with SPOP via a conservative degron motif. Importantly, cancer-derived mutations in SPOP or at the Nanog-degron (S68Y) disrupt SPOP-mediated destruction of Nanog, leading to elevated cancer stem cell traits and PrCa progression. Notably, we identify the Pin1 oncoprotein as an upstream Nanog regulator that impairs its recognition by SPOP and thereby stabilizes Nanog. Thus, Pin1 inhibitors promote SPOP-mediated destruction of Nanog, which provides the molecular insight and rationale to use Pin1 inhibitor(s) for targeted therapies of PrCa patients with wild-type SPOP.
Insights
SPOP suppresses prostate cancer (PrCa) by degrading Nanog, a key stem cell factor. Mutations disrupting this process promote PrCa progression, suggesting Pin1 inhibitors as a targeted therapy for wild-type SPOP PrCa.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Stem Cells
Background:
- SPOP mutations are a hallmark of a specific prostate cancer (PrCa) subtype.
- The tumor-suppressive role of SPOP in PrCa remains poorly understood.
- Understanding SPOP's function is crucial for developing targeted PrCa therapies.
Purpose of the Study:
- To elucidate the molecular mechanism by which SPOP suppresses stem cell traits in PrCa.
- To investigate the interaction between SPOP and Nanog in the context of PrCa.
- To identify potential therapeutic strategies targeting SPOP-mutated or wild-type PrCa.
Main Methods:
- Investigated SPOP's role in regulating Nanog ubiquitination and degradation.
- Analyzed the interaction between SPOP and Nanog using biochemical assays.
- Examined the impact of SPOP and Nanog mutations on cancer stem cell traits and PrCa progression.
- Identified Pin1 as an upstream regulator of Nanog stability.
Main Results:
- SPOP suppresses stem cell traits by promoting Nanog poly-ubiquitination and degradation.
- Nanog specifically interacts with SPOP via a degron motif, unlike Oct4, Sox2, and Klf4.
- Cancer-associated mutations in SPOP or Nanog disrupt Nanog degradation, enhancing cancer stem cell traits and PrCa progression.
- Pin1 stabilizes Nanog by hindering its recognition by SPOP.
Conclusions:
- SPOP acts as a tumor suppressor in PrCa by controlling Nanog stability.
- Disruption of the SPOP-Nanog interaction drives PrCa progression.
- Pin1 inhibitors can promote Nanog degradation, offering a therapeutic avenue for PrCa patients with wild-type SPOP.
Related Concept Videos
Trait and State Self-Esteem
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Polygenic Traits
Multiple Allele Traits
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

